SKP Merrill Lynch

SCPIE Holdings Inc. (NYSE:SKP), a major provider of healthcare liability insurance, today announced that based on unofficial early results, significantly more than the 50% of outstanding shares necessary for approval were voted FOR the adoption of the merger agreement with The Doctors Company, a leading physician-owned medical malpractice carrier. The merger agreement provides for the purchase of SCPIE for $28.00 per share in cash, or an aggregate purchase price of approximately $281 million. In addition to approval by SCPIE�s stockholders, the transaction is subject to the receipt of insurance regulatory approvals. The final vote count by the independent inspectors of election, IVS Associates Inc., is expected within two weeks. Forward-Looking Statements In addition to historical information, this news release contains forward-looking statements that are based upon the Company�s estimates and expectations concerning future events and are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Risks and uncertainties regarding the pending transaction with The Doctors Company include the possibility that the closing does not occur, or is delayed, due to the failure of closing conditions (including approval by the Company�s stockholders and regulatory authorities) and risks that the pending transaction could disrupt current plans and opportunities of the Company. Other factors that may cause actual results to differ from the forward-looking statements contained herein and that may affect the Company�s prospects are included in the Company�s other filings with the Securities and Exchange Commission. In light of the significant uncertainties inherent in the forward-looking information herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the Company�s objectives or plans will be realized.